Navigation Links
Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections
Date:9/6/2010

create an environment in which microbes are awash in antibiotics, which speeds the process of resistance, he says.

"Right now, pharmaceutical companies are rewarded for actions that conflict with the public health goal of reducing antibiotic resistance," Outterson says. "That has to stop."

The analysis in Health Affairs crafts an innovative solution to the problem, one that gives pharmaceutical companies financial incentives to market drugs in a way that would keep resistance rates at low levels.

Specifically, Kesselheim and Outterson suggest that government experts study the rates of resistance and set "effectiveness targets" for newly approved antibiotics. To meet those goals, which the authors say would be based on factors related to the disease targeted by the antibiotic, such as lower resistance rates, drug companies would need to coordinate with physicians and hospitals so that the drugs are prescribed only when clinically indicated. Such action would remove the current incentive to oversell.

Companies that met the predetermined targets (achieved through responsible use of the drugs) would be rewarded. For example, the authors suggest that Medicare could pay a bonus to companies producing drugs that meet their resistance targets. Or policy-makers could grant such companies extended market exclusivity so they could continue to earn revenuesas long as the drug use remained within the target zone.

Such a policy could help slow development of resistance in microbes and ensure new antibiotics have a longer shelf life, a bonus that would help not just individual patients but society as a whole, Kesselheim and Outterson predict.

The authors, and other experts, say that the United States must adopt more comprehensive strategies that give drug companies and others incentives to reduce antibiotic resistance. For example, hospitals should be financially rewarded for adhering to strict infection-control practic
'/>"/>

Contact: Becky Wexler
bwexler@burnesscommunications.com
301-652-1558
Burness Communications
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Pharmaceuticals: A market for producing lemons and serious harm
2. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
3. The malicious use of pharmaceuticals: An under-recognized form of child abuse
4. Mary Hendrickson of GENCO Pharmaceutical Services Speaks Before Senate on the Topic of Drug Take-Back Programs
5. SDI Reports: Novo Nordisk Takes Top Ranking Among Endocrinologists, According To Pharmaceutical Company Image Study
6. Chinese Biopharmaceutical Association Successfully Holds 15th Annual Conference
7. Omega Design Presented Pharmaceutical Packaging Solutions at the Healthcare Packaging Conference & Workshop 2010
8. HR Pharmaceuticals, Inc. to Launch and Showcase Flagship Product Line at the National Teaching Institute & Critical Care Nurses Exposition
9. Pharmaceutical companies provide EPA 100 drugs to help predict toxicity
10. HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings
11. SDI Reports: Pharmaceutical Promotion Spending Indicates Trend Toward Electronic and Online Promotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 Hexagon Geospatial is ... Defence and Space in a new content-sharing program that ... for use in the development of smart applications. ... this partnership combines optical satellite data from Airbus Defence ... tear down the walls between geospatial content, software and ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 i2i Systems, ... solutions for more than 15 years, has earned 2014 ... Committee for Quality Assurance (NCQA) for its flagship product ... are proud of the work we have done to ... grateful for the acknowledgement from NCQA once again,” said ...
(Date:5/26/2015)... 2015 Scientists at the University of ... help advanced mesothelioma patients benefit from immunotherapy; surgery may ... article on the new research. Click here to ... of thoracic surgery and pulmonology theorized that, because large ... system attack, immunotherapy drugs might work better if the ...
(Date:5/26/2015)... 2015 ProTrailer Network is a new ... Pro X . This Effect includes 30 all ... styled text. , ProTrailer Network allows users to ... can easily complement any form of media project. FCPX ... can make professional looking openers. , ProTrailer Network includes ...
(Date:5/26/2015)... 2015 Learning ZoneXpress is excited to ... Education Cards . These cards have been specifically designed ... simple, easy-to-read text, these new educational resources are extremely ... practical nutrition tips and suggestions to clients and provide ... , + MyPlate: Eat for a Healthy Baby Pregnancy ...
Breaking Medicine News(10 mins):Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 2Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2
... a forewarning from severe periodontal disease than non-diabetic pregnant ... periodontology.// ,Researchers from the University of Iowa Colleges ... and 20 non-diabetic women in their 20-39th week of ... the control of diabetes. They found the diabetics flaunted ...
... men who eat up tomato products more than twice ... prostate cancer. Consuming cooked tomatoes was particularly beneficial, according ... sauce, ketchup and other tomato-based foods lowered the prostate ... ,Dr. Edward Giovannucci of Brigham and Women's Hospital and ...
... transplant patients contracted a dangerous parasitic disease from their ... women died, but only one recovered after antibiotic treatment.// ... Disease Control and Prevention turned up 26 bacterial infections ... in the United States. ,This shows that the ...
... medications than smokers, as the extra weight poses them ... the nation's principal cause of preventable deaths, the surgeon ... ,For a more precise look at the ... from two national health surveys to estimate inpatient and ...
... Getting cold out of doors condenses the blood and increases ... of University of Texas, it has been found that too ... - in Britain. He believes that cold temperatures alter the ... raises the risk of clotting and heart attack. ...
... gender were among the best indicators of how you might ... state-by-state study of prescription drug use, where you live also ... you use. // ,According to the study, the percentage ... ranged from a high of 71 percent in Kansas to ...
Cached Medicine News:Health News:Prescription Drug Use Varies Widely Between States 2
(Date:5/26/2015)... May 26, 2015 For the ... Quality of Life Throughout Europe, the Middle ... Astellas Pharma EMEA is celebrating its 10 ... through the historic merger of Japanese pharmaceutical companies Yamanouchi ... committed to turning science into value for patients through ...
(Date:5/22/2015)... May 22, 2015  Research and Benchmarking firm, ... Medical Affairs Roundtable on Thursday, May ... virtual roundtable to discuss "Medical Affairs, Role in ... Practices, Medical Affairs Consortium provides Medical Affairs leaders ... key challenges they face. The consortium has developed ...
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
Breaking Medicine Technology:Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
... The Pittsburgh Life Sciences Greenhouse (PLSG), ... formation and business growth programs to the region,s ... President and Chief Executive Officer, John W. ... signing an agreement with Ortho-McNeil-Janssen Pharmaceuticals, a Johnson ...
... Pa. , June 22 TheraQuest Biosciences, Inc., a ... TheraQuest also announced the launch of its new corporate website at ... , ... a careful strategic review of our pipeline, we have realigned our ...
Cached Medicine Technology:The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy 2TheraQuest Unveils New Pain Management Product Pipeline 2TheraQuest Unveils New Pain Management Product Pipeline 3TheraQuest Unveils New Pain Management Product Pipeline 4TheraQuest Unveils New Pain Management Product Pipeline 5
Part of the Octopus System which includes both the Starfish & Octopus3. The Octopus3 Tissue Stabilizer is the pioneering and market-leading suction device....
... way to lift the heart - Guidant's ... 3. The XPOSE 3 is designed to ... surgery and to easily position and access ... both apical and non-apical placement on the ...
... The CLEARGLIDE Optical Vessel Dissector has application ... operative cavity in the extraperitoneal spaces such ... The device may be used in surgical ... EVH system enables harvesting of a quality ...
The MicroMed DeBakey VAD is a miniaturized heart pump designed to provide increased blood flow (up to 10L/min) from the left ventricle of the heart throughout the body for patients in end stage heart...
Medicine Products: